Table 6 Demographics and baseline characteristics of ‘earlier discharge’ population
Rezafungin N = 15/93 (16%) | Caspofungin N = 15/94 (16%) | All patients N = 30/187 (16%) | |
|---|---|---|---|
Mean age (Years, SD) | 52.3 (16.58) | 60.6 (12.88) | 56.5 (15.18) |
Age > = 18− < 65 | 10 (66.7%) | 9 (60%) | 19 (63%) |
Male gender | 8 (53.3%) | 9 (60%) | 17 (57%) |
Initial diagnosis | |||
Candidemia only | 13 (86.7%) | 12 (80%) | 83% |
Invasive candidiasis | 2 (13.3%) | 3 (20%) | 17% |
Top 3 represented risk factors | |||
Broad-spectrum antibiotic therapy | 11 (73.3%) | 8 (53.3%) | 19 (63.3%) |
Central venous catheter | 8 (53.3%) | 9 (60%) | 17 (56.7%) |
Major surgery | 8 (53.3%) | 6 (40%) | 14 (46.7%) |
ICU involvement | |||
ICU at any time | 3 (20%) | 5 (33.3%) | 8 (26.7%) |
ICU at randomisation | 2 (13.3%) | 5 (33.3%) | 7 (23.3%) |
Baseline Modified Apache II Score | |||
< 20 | 13 (86.7%) | 12 (80%) | 83% |
> = 20 | 2 (13.3%) | 3 (20%) | 17% |